- Home
- HOVNP vs SRPT Comparison
HOVNP vs SRPT Comparison
Compare HOVNP & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOVNP
- SRPT
- Stock Information
- Founded
- HOVNP N/A
- SRPT 1980
- Country
- HOVNP United States
- SRPT United States
- Employees
- HOVNP 1878
- SRPT N/A
- Industry
- HOVNP Homebuilding
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- HOVNP Consumer Discretionary
- SRPT Health Care
- Exchange
- HOVNP Nasdaq
- SRPT Nasdaq
- Market Cap
- HOVNP N/A
- SRPT N/A
- IPO Year
- HOVNP N/A
- SRPT 1997
- Fundamental
- Price
- HOVNP $16.40
- SRPT $17.20
- Analyst Decision
- HOVNP
- SRPT Buy
- Analyst Count
- HOVNP 0
- SRPT 25
- Target Price
- HOVNP N/A
- SRPT $64.00
- AVG Volume (30 Days)
- HOVNP N/A
- SRPT 7.5M
- Earning Date
- HOVNP N/A
- SRPT 08-06-2025
- Dividend Yield
- HOVNP N/A
- SRPT N/A
- EPS Growth
- HOVNP N/A
- SRPT N/A
- EPS
- HOVNP N/A
- SRPT N/A
- Revenue
- HOVNP N/A
- SRPT $2,233,371,000.00
- Revenue This Year
- HOVNP N/A
- SRPT $26.87
- Revenue Next Year
- HOVNP N/A
- SRPT $3.15
- P/E Ratio
- HOVNP N/A
- SRPT N/A
- Revenue Growth
- HOVNP N/A
- SRPT 59.15
- 52 Week Low
- HOVNP N/A
- SRPT $16.96
- 52 Week High
- HOVNP N/A
- SRPT $162.95
- Technical
- Relative Strength Index (RSI)
- HOVNP 57.02
- SRPT 18.61
- Support Level
- HOVNP $16.16
- SRPT $18.30
- Resistance Level
- HOVNP $16.58
- SRPT $22.98
- Average True Range (ATR)
- HOVNP 0.26
- SRPT 1.98
- MACD
- HOVNP 0.03
- SRPT -1.19
- Stochastic Oscillator
- HOVNP 48.15
- SRPT 0.89
About HOVNP Hovnanian Enterprises Inc Dep Shr Srs A Pfd
Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations . The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments; Northeast which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia and West Virginia; Southeast which includes Florida, Georgia and South Carolina; and West which includes Arizona, California and Texas. The firm generates maximum revenue from West Segment.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.